Nano Labs Ltd

Aktienanalyse zu Nano Labs Ltd (NA)

$1.345

-0.053 (-3.93%)Zum Schluss

Loading chart…
Hoch
1.550
Eröffnung
1.410
Volumengewichteter Durchschnittskurs
1.41
Volumen
32.89K
Marktkap.
30.98M
Tief
1.320
Umsatz
46.20K
EV/EBITDA, TTM
0.00

Nano Labs Ltd is a holding company mainly engaged in the provision of fabless integrated circuit (IC) and product solutions. The Company is mainly engaged in the development of high throughput computing (HTC) chips, high performance computing (HPC) chips, distributed computing and storage solutions, smart network interface cards (NICs) vision computing chips and distributed rendering. The Company conducts its businesses primarily through its subsidiaries. The Company mainly conducts its businesses in the domestic market and overseas markets.

KI-Analyse of Nano Labs Ltd (NA)

Verkaufen

Given the current price of 1.345 and a significant RSI of 25.259 indicating oversold conditions, the stock may seem attractive. However, the company has reported a staggering 66.7% revenue decline and a net income loss of 154,751,884 CNY in Q1 2026, which raises serious concerns about its financial health. The forward P/E ratio is effectively zero, indicating no expected profitability in the near term. The main risk is the company's 58.99% year-to-date decline, suggesting a lack of investor confidence and potential for further losses.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Nano Labs Ltd (NA) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für NA

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%NA

$8.55

Szenariopreis

B

Basis

Basis · 50%NA

$8.33

Szenariopreis

B

Bärisch

Bärisch · 25%NA

$7.53

Szenariopreis

Whales, die NA halten

L

La Caisse de dépôt et placement du Québec

+ HältNA

+53.11%

3-Monats-Rendite

F

Fiera Capital Corporation

+ HältNA

+8.42%

3-Monats-Rendite

R

RBC Global Asset Management Inc.

+ HältNA

+7.51%

3-Monats-Rendite

P

Picton Mahoney Asset Management

+ HältNA

+7.38%

3-Monats-Rendite

I

Industrielle Alliance, Gestion de placements inc.

+ HältNA

+7.35%

3-Monats-Rendite

H

Hillsdale Investment Management Inc.

+ HältNA

+7.14%

3-Monats-Rendite

Event-Zeitleiste

2026-08-31 (ET)

06:30:00

Nano Labs Director Nan Hu Resigns, Effective August 31, 2026

2026-04-24 (ET)

06:10:00

Nano Labs Signs MOU with ALT5 Sigma for Collaboration

2026-03-06 (ET)

07:10:00

Nano Labs Launches iPollo ClawPC A1 Mini Hardware Product

2025-12-31 (ET)

08:10:00

Nano Labs Completes New Round of BNB Acquisitions, Holding Over 130,000 BNB

08:10:00

Company Initiates $25M Share Repurchase Program

News

NA FAQ – beantwortet von Alphio AI

Nano Labs Ltd is a holding company mainly engaged in the provision of fabless integrated circuit (IC) and product solutions. The Company is mainly engaged in the development of high throughput computing (HTC) chips, high performance computing (HPC) chips, distributed computing and storage solutions, smart network interface cards (NICs) vision computing chips and distributed rendering. The Company conducts its businesses primarily through its subsidiaries. The Company mainly conducts its businesses in the domestic market and overseas markets. It operates in the Technology sector (SEMICONDUCTORS AND RELATED DEVICES industry).

Given the current price of 1.345 and a significant RSI of 25.259 indicating oversold conditions, the stock may seem attractive. However, the company has reported a staggering 66.7% revenue decline and a net income loss of 154,751,884 CNY in Q1 2026, which raises serious concerns about its financial health. The forward P/E ratio is effectively zero, indicating no expected profitability in the near term. The main risk is the company's 58.99% year-to-date decline, suggesting a lack of investor confidence and potential for further losses.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln